Biovaccines Nigeria Limited, a partnership with the Federal  government was incorporated in 2005. The company is owned 51 per cent by May & Baker Nigeria Plc. and 49 per cent by the Federal Government.
It is a vaccine production and distribution company.
The company is currently located at two facilities in  Yaba, Lagos, as follows
445, Herbert Macaulay Way, Yaba and  no. 1 university road, Yaba, Lagos State.
The objective of Biovaccines Nigeria Limited is to produce safe and affordable human vaccines for Nigeria and reverse the situation of high mortality from immunizable diseases. It also plans to create a regional centre for vaccine production in West Africa and position Nigeria as a global player in vaccine business.
The  Yaba facilities are being resuscitated for renewal of production of yellow fever and measles  vaccines with plans for an  ultra modern vaccine plant in Ota, Ogun State expected to produce the following vaccines:
HPV, Diphteria, Toxid and Pertusis (DTP) and Tetanus Toxid (TT).  
The planned facility has capacity for;
Hep-B             25 million doses
DTP                 20 million  doses
DT (Children)            5 million doses
DT (Adult)     5 million doses
TT                   20 million doses
DTP+Hep-B    5 million doses.

Picture Speaks

Tweet May & Baker

May & Baker Vacancies

job openings